<DOC>
	<DOCNO>NCT01265069</DOCNO>
	<brief_summary>Currently , 10-day concomitant therapy report equally effective safe 10-day sequential therapy 1st-line anti-Helicobacter pylorus ( H. pylorus ) therapy . To knowledge , report concern efficacy regimen use rescue therapy . The aim study : 1. compare efficacy high dose dual therapy concomitant therapy rescue regimen H. pylori eradication ; 2. compare patient adherence adverse effect treatment regimens ; 3. investigate factor may influence H. pylorus eradication treatment regimen .</brief_summary>
	<brief_title>Efficacy 10-day Concomitant Regimen Versus High Dose Dual Therapy Anti-Helicobacter Pylori Rescue Therapy</brief_title>
	<detailed_description>Patients , age 18 , H. pylori-positive chronic gastritis with/without peptic ulcer recruit . All undergo endoscopy biopsy treatment . Four eight week termination treatment , H. pylori infection status examine endoscopy biopsy Carbon 13-urea breath test patient refuse second endoscopy . The cytochrome P450 ( CYP ) 2C19 genotype participant analyze polymerase chain reaction-based restriction fragment length polymorphism ( PCR-RFLP ) method . A compute generated random number sequence block two subgroup , say A B . If patient receive anti-H. pylori therapy previously , invite enter study evaluate efficacy rescue regimen . After give write informed consent , patient label number enrol order . Each patient randomly allocate one two treatment group receive medication 10 14 day : group A - high dose dual therapy ( rabeprazole 20 mg qid + amoxicillin 750 mg qid 14 day ) ; group B - concomitant therapy ( rabeprazole 20 mg + amoxicillin 1000 mg + metronidazole 500 mg + clarithromycin 500 mg , bid 10 day ) . All patient ask complete questionnaire record symptoms drug consumption daily diary card treatment period . Post-treatment , patient see Outpatient Clinic investigate patient adherence adverse effect treatment .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>patient H. pylori relate chronic gastritis with/without peptic ulcer age great 18 year willing receive eradication therapy . pregnant nursing woman serious concomitant illness malignant tumor kind history hypersensitivity test drug serious bleed course ulcer previous gastric surgery receive bismuth salt , proton pump inhibitor , antibiotic previous month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>concomitant therapy</keyword>
	<keyword>high dose dual therapy</keyword>
	<keyword>antibiotic resistance</keyword>
</DOC>